Is this 5% yielding dividend stock a no-brainer?

This stock has risen a long way from its lows in 2016. But with a yield above 5%, is it a dividend share worth owning now? This is what I’d do about it.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

FTSE 100 mining giant BHP (LSE: BHP) today delivered its operational review for the trading half-year to 31 December 2020. Chief executive Mike Henry said in the report the company achieved a “strong” operational performance in the period. The stock moved higher today in early trading, continuing a strong rebound from the lows of last spring. And with the share price near 2,158p, it’s close to its all-time high of just above 2,200p achieved just under a decade ago.

BHP’s ‘lost’ decade

That situation underlines a pertinent fact. If I’d invested a decade ago near the previous high, I’d only now be near to breaking even on my original invested capital. Of course, there have been dividends along the way to soften the blow a bit. But essentially, the value of my invested capital will have been underwater until now.

I reckon there’s been a huge opportunity cost for those holding BHP for 10 years. Many great stock investments have passed my screen over that time and my money could have been in many of them, working hard for me. Instead, though, it would have been languishing in BHP.

Meanwhile, the dividend record is a little patchy. For example, in 2015 the total dividend was $1.29. In 2016, it was $0.29. City analysts expect the shareholder payment to be around $1.79 this year but to drop to about $1.62 next year. And that level throws up a forward-looking yield of around 5.5%.

The share price has been all over the place too, even dropping as low as about 600p in early 2016. In hindsight, that would have been a good time to load up with the stock to ride the cyclical recovery. But what about now? I’m not so sure.

Commodity prices riding high

It almost goes without saying the trading outcomes for a cyclical mining company like BHP are heavily dependent on the prevailing prices for the commodities it deals with. BHP has operations in things like copper, iron ore, coal, nickel, and oil. And a quick glance reveals prices for all those commodities have been riding high lately.

I reckon robust commodity prices potentially signal a decent general economic recovery brewing. But I’d question whether a miner like BHP is the best way for me to benefit. It’s tricky timing a good entry into out-and-out cyclical stocks. And dividend yields can be an unreliable indicator. For example, the UK-listed banks had high-looking yields for years – and then they crashed.

However, Henry reckons BHP is well-positioned to sustainably grow shareholder and social value as the global economy recovers from the pandemic”. But for me, there are stocks with high dividend yields and the potential for capital growth elsewhere. And rather than being a no-brainer, I’d put cyclical shares like BHP on the ‘too tricky’ pile.

Instead, I like the consistent cash-generating and dividend-paying qualities of companies such as GlaxoSmithKline, National Grid, and Tate & Lyle right now. So, I’ll stick with those for the time being.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »